patent
New Developments in CRISPR Patent Case
New Developments in CRISPR Patent Case
Jef Akst | Dec 12, 2016
Documents suggest Feng Zhang started working on CRISPR before Jennifer Doudna’s group published; researchers call for CRISPR technology to be shared openly
CRISPR Oral Arguments Recap, Cont’d
CRISPR Oral Arguments Recap, Cont’d
Jef Akst | Dec 8, 2016
This week’s CRISPR patent hearing took a deep dive into the science of moving the gene-editing technology from prokaryotes to eukaryotic systems.
USPTO to Hear Arguments on CRISPR Patents
USPTO to Hear Arguments on CRISPR Patents
Jef Akst | Dec 5, 2016
Tuesday morning, the US Patent and Trademark Office will hear oral arguments from the two parties that claim to have been the first to use CRISPR-Cas9 gene editing technology in eukaryotic cells.
Week in Review: August 29–September 2
Week in Review: August 29–September 2
Jef Akst | Sep 2, 2016
Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer
That Other CRISPR Patent Dispute
That Other CRISPR Patent Dispute
Kerry Grens | Aug 31, 2016
The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.
Opinion: How to Avoid Legal Problems in Collaborative Research
Opinion: How to Avoid Legal Problems in Collaborative Research
Catherine Coombes | Aug 31, 2016
A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.
Student Alleges His Team Didn’t Earn CRISPR Patent
Student Alleges His Team Didn’t Earn CRISPR Patent
Kerry Grens | Aug 18, 2016
A former researcher at the Broad Institute has suggested the University of California, Berkeley, team deserves credit for inventing the gene-editing technique.
Do Patents Promote or Stall Innovation?
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Another Gene-Editing IPO
Another Gene-Editing IPO
Bob Grant | Apr 12, 2016
Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.
CRISPR Patent Investigation to Begin
CRISPR Patent Investigation to Begin
Jef Akst | Mar 9, 2016
The US Patent and Trademark Office is set to launch its “patent interference” inquiry into the competing patents on the gene-editing technology.